These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application. Haaland RE, Evans-Strickfaden T, Holder A, Pau CP, McNicholl JM, Chaikummao S, Chonwattana W, Hart CE. Antimicrob Agents Chemother; 2012 Jul; 56(7):3592-6. PubMed ID: 22508307 [Abstract] [Full Text] [Related]
6. Development and characterisation of a self-microemulsifying drug delivery systems (SMEDDSs) for the vaginal administration of the antiretroviral UC-781. McConville C, Friend D. Eur J Pharm Biopharm; 2013 Apr; 83(3):322-9. PubMed ID: 23159711 [Abstract] [Full Text] [Related]
7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM, Elkheshen SA, Ghorab MM. Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [Abstract] [Full Text] [Related]
8. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling. Adhikari S, Daftardar S, Fratev F, Rivera M, Sirimulla S, Alexander K, Boddu SHS. Int J Pharm; 2018 Jul 10; 545(1-2):357-365. PubMed ID: 29747001 [Abstract] [Full Text] [Related]
14. In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1. Hossain MM, Parniak MA. J Virol; 2006 May 10; 80(9):4440-6. PubMed ID: 16611904 [Abstract] [Full Text] [Related]